Abstract
Dengue virus serotypes 1–4 (DENV1–4) are mosquito-borne human pathogens of global significance causing ~390 million cases annually worldwide. The virus infections cause in general a self-limiting disease, known as dengue fever, but occasionally also more severe forms, especially during secondary infections, dengue hemorrhagic fever and dengue shock syndrome causing ~25,000 deaths annually. The DENV genome contains a single-strand positive sense RNA, approximately 11 kb in length. The 5′-end has a type I cap structure. The 3′-end has no poly(A) tail. The viral RNA has a single long open reading frame that is translated by the host translational machinery to yield a polyprotein precursor. Processing of the polyprotein precursor occurs co-translationally by cellular proteases and posttranslationally by the viral serine protease in the endoplasmic reticulum (ER) to yield three structural proteins (capsid (C), precursor membrane (prM), and envelope (E) and seven nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). The active viral protease consists of both NS2B, an integral membrane protein in the ER, and the N-terminal part of NS3 (180 amino acid residues) that contains the trypsin-like serine protease domain having a catalytic triad of H51, D75, and S135. The C-terminal part of NS3, ~170–618 amino acid residues, encodes an NTPase/RNA helicase and 5′-RNA triphosphatase activities; the latter enzyme is required for the first step in 5′-capping. The cleavage sites of the polyprotein by the viral protease consist of two basic amino acid residues such as KR, RR, or QR, followed by short chain amino acid residues, G, S, or T. Since the cleavage of the polyprotein by the viral protease is absolutely required for assembly of the viral replicase, blockage of NS2B/NS3pro activity provides an effective means for designing dengue virus (DENV) small-molecule therapeutics. Here we describe the screening of small-molecule inhibitors against DENV2 protease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lindenbach D, Thiel HJ, Rice C (2007) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Field’s Virology, vol 1, 5th edn. Lippincott-Raven Publishers, Philadelphia, pp 1101–1152
Lambrechts L, Scott TW, Gubler DJ (2010) Consequences of the expanding global distribution of aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis 4(5):e646. doi:10.1371/journal.pntd.0000646
Mitka M (2013) Dengue more prevalent than previously thought. JAMA 309(18):1882. doi:10.1001/jama.2013.4903
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8(12 Suppl):S7–S16. doi:nrmicro2460, [pii] 10.1038/nrmicro2460
Sampath A, Padmanabhan R (2009) Molecular targets for flavivirus drug discovery. Antiviral Res 81(1):6–15. doi:S0166-3542(08)00386-0, [pii] 10.1016/j.antiviral.2008.08.004
Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, Wang QY, Shi PY (2010) Strategies for development of dengue virus inhibitors. Antiviral Res 85(3):450–462. doi:S0166-3542(10)00004-5, [pii] 10.1016/j.antiviral.2009.12.011
Clum S, Ebner KE, Padmanabhan R (1997) Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B. J Biol Chem 272(49):30715–30723
Falgout B, Miller RH, Lai C-J (1993) Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol 67:2034–2042
Chambers TJ, Nestorowicz A, Amberg SM, Rice CM (1993) Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. J Virol 67(11):6797–6807
Li J, Lim SP, Beer D, Patel V, Wen D, Tumanut C, Tully DC, Williams JA, Jiricek J, Priestle JP, Harris JL, Vasudevan SG (2005) Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem 280(31):28766–28774
Feng BY, Shoichet BK (2006) A detergent-based assay for the detection of promiscuous inhibitors. Nat Protoc 1(2):550–553. doi:10.1038/nprot.2006.77
Ezgimen MD, Mueller NH, Teramoto T, Padmanabhan R (2009) Effects of detergents on the west nile virus protease activity. Bioorg Med Chem 17(9):3278–3282. doi:S0968-0896(09)00310-1, [pii] 10.1016/j.bmc.2009.03.050
Acknowledgments
The research was supported by an NIH grant, AI082068 to R.P.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Lai, H., Teramoto, T., Padmanabhan, R. (2014). Construction of Dengue Virus Protease Expression Plasmid and In Vitro Protease Assay for Screening Antiviral Inhibitors. In: Padmanabhan, R., Vasudevan, S. (eds) Dengue. Methods in Molecular Biology, vol 1138. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0348-1_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0348-1_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0347-4
Online ISBN: 978-1-4939-0348-1
eBook Packages: Springer Protocols